SGLT2 inhibitors and renal outcomes in type 2 diabetes with or without renal impairment: A systematic review and meta-analysis

• SGLT2 inhibition is associated with a transient decrease in eGFR. • SGLT2 inhibition prevents deterioration of renal function and death from kidney disease. • In populations with renal impairment, SGLT2-Is are associated with preservation of renal function. • SGLT2-Is are associated with improveme...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
1. Verfasser: Seidu, Samuel (VerfasserIn)
Weitere Verfasser: Kunutsor, Setor K. (BerichterstatterIn), Cos, Xavier (BerichterstatterIn), Gillani, Syed (BerichterstatterIn), Khunti, Kamlesh (BerichterstatterIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2018
Zugriff auf das übergeordnete Werk:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Schlagworte:Type 2 diabetes Renal impairment SGLT2 inhibitor
Umfang:19